Echolight is a revenue stage Italian high-tech biomedical company founded in 2010 that has developed an innovative device for the diagnosis and monitoring of osteoporosis through the R.E.M.S. technology.
R.E.M.S. (Radiofrequency Echographic Multi Spectrometry) is an innovative echographic approach based on radiofrequency that determines the status of internal bone micro-architecture at the reference axial sites.
This non-invasive technology demonstrated equivalence with current standard of care (DEXA, an invasive technique) without the need of dangerous ionizing radiations and has been validated on more than 10.000 subjects in international multi-center studies.
Thanks to R.E.M.S. it will be possible to find many undiagnosed cases allowing both screening, diagnosis and monitoring of these patients.
The product is CE marked and FDA approved.